South East London Joint Medicines Formulary Formulary

	South East London Joint Medicines Formulary
	Guy's and St Thomas' NHS Foundation Trust Kings College Hospital NHS Foundation Trust Lewisham and Greenwich NHS Trust

Search

Formulary Chapter 6: Endocrine system - Full Chapter

Chapter Links...

SE London APC Blood Glucose Control Management Pathway for Adults with Type 2 Diabetes Mellitus (T2DM)

Details...

06.02.02

Antithyroid drugs

Aqueous Iodine oral solution (Lugol's)

Formulary

Carbimazole tabs

Formulary

Refer to BNF for CSM advice on neutropenia and agranulocytosis

Propylthiouracil tabs

Formulary

Methylthioninium chloride injection 0.5%, 1%, 2% (methylene blue)

Unlicensed

Diagnostic agent used for staining parathyroid glands. Maximal staining of glands occurs if infused intravenously for 1 hour prior to operation Dose: 5 mg/kg actual body weight in 250 mL dextrose/saline

MHRA Apr 2009: Methylthioninium chloride (methylene blue): update on central nervous system (CNS) toxicity with serotonergic antidepressants

Methylthioninium chloride injection 2% (methylene blue)

Unlicensed

For testing intragastric balloon insertions and as a dye for patients with polyps undergoing colonoscopies (Endoscopy/Day Surgery) For checking bladder patency secondary to injury during C-sections and checking fallopian tube patency (Birth Centre Theatres)

MHRA Apr 2009: Methylthioninium chloride (methylene blue): update on central nervous system (CNS) toxicity with serotonergic antidepressants

Potassium Iodate tabs

Unlicensed

Protection of thyroid function during radioactive iodine therapy Dose: 130 mg daily

....

Key

	Notes
	Section Title (top level)
	Section Title (sub level)
	First Choice item
	Non Formulary section
	Restricted Drug
	Unlicensed
	Display tracking information
	Link to adult BNF
	Link to SPCs
	Scottish Medicines Consortium

	Cytotoxic Drug
	Controlled Drug
	High Cost Medicine
	Cancer Drugs Fund
	NHS England
	Homecare
	CCG

Traffic Light Status Information

Status	Description
	Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.
	Treatment can be initiated in primary care after a recommendation from an appropriate specialist
	Specialist initiation followed by maintenance prescribing in primary care
	Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation
	Specialist and non-specialist initiation
	Not recommended for prescribing